Abstract
It is estimated that 20% of the adult world population suffers from anxiety. This disease is manifested by feelings of psychic malaise, translated by a variety of somatic disorders related to autonomic hyperactivity. The pharmaceutical industry has a large therapeutic arsenal for anxiety, however, generating numerous adverse effects on its users. Thus, the search for safer and more effect…